Form 4 Filing for Maranore John at Kymera Therapeutics, Inc.

This Form 4 filing details a stock option grant to John Maranore, a director at Kymera Therapeutics, Inc. (KYMR). The option, with a right to buy, was granted on June 24, 2026, and is exercisable at $99.87 per share. The underlying security is Common Stock. The option vests in full on the earlier of June 24, 2027, or the next annual stockholder meeting. Following the transaction, Maranore holds 6,068 shares, acquired through this option grant.